Treatment frequency and mortality among incident hemodialysis patients in the United States comparing incremental with standard and more frequent dialysis

Kidney International

Volumn 90, Issue 5, 2016, Pages 1071-1079

  Mathew, Anna ^a   Obi, Yoshitsugu ^b   Rhee, Connie M ^b   Chen, Joline L T ^c   Shah, Gaurang ^b   Lau, Wei Ling ^b   Kovesdy, Csaba P ^d,e   Mehrotra, Rajnish ^f   Kalantar Zadeh, Kamyar ^b,g,h  

^a Northwell Health   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

chronic kidney disease; hemodialysis; incremental; mortality

Indexed keywords

ADULT; ARTICLE; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; END STAGE RENAL DISEASE; FEMALE; HAZARD RATIO; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SENSITIVITY ANALYSIS; UNITED STATES; AGED; EPIDEMIOLOGY; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; RETROSPECTIVE STUDY; UTILIZATION;

AGED; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84994138793     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.05.028     Document Type: Article

References (41)

1. 1 Saran, R., Li, Y., Robinson, B., US Renal Data System 2014 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis 66:suppl 1 (2015), S1–S306.
2. 2 Rhee, C.M., Unruh, M., Chen, J., et al. Infrequent dialysis: a new paradigm for hemodialysis initiation. Semin Dial, 26, 2013, 720727.
3. 3 Blagg, C.R., Hemodialysis 1991. Blood Purif 10 (1992), 22–29.
4. 4 Kalantar-Zadeh, K., Casino, F.G., Let us give twice-weekly hemodialysis a chance: revisiting the taboo. Nephrol Dial Transplant 29 (2014), 1618–1620.
5. 5 Lukowsky, L.R., Kheifets, L., Arah, O.A., et al. Patterns and predictors of early mortality in incident hemodialysis patients: new insights. Am J Nephrol 35 (2012), 548–558.
6. 6 Bradbury, B.D., Fissell, R.B., Albert, J.M., et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2 (2007), 89–99.
7. 7 Eknoyan, G., Beck, G.J., Cheung, A.K., et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347 (2002), 2010–2019.
8. 8 Lowrie, E.G., Laird, N.M., Parker, T.F., Sargent, J.A., Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 305 (1981), 1176–1181.
9. 9 Chertow, G.M., Levin, N.W., Beck, G.J., et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med 363 (2010), 2287–2300.
10. 10 Chertow, G.M., Levin, N.W., Beck, G.J., et al. Long-term effects of frequent in-center hemodialysis. J Am Soc Nephrol 27 (2016), 1830–1836.
11. 11 Rocco, M.V., Lockridge, R.S. Jr., Beck, G.J., et al. The effects of frequent nocturnal home hemodialysis: The Frequent Hemodialysis Network Nocturnal Trial. Kidney Int 80 (2011), 1080–1091.
12. 12 Rocco, M.V., Daugirdas, J.T., Greene, T., et al. Long-term effects of frequent nocturnal hemodialysis on mortality: the Frequent Hemodialysis Network (FHN) Nocturnal Trial. Am J Kidney Dis 66 (2015), 459–468.
13. 13 Daugirdas, J.T., Greene, T., Rocco, M.V., et al. Effect of frequent hemodialysis on residual kidney function. Kidney Int 83 (2013), 949–958.
14. 14 Lin, Y.F., Huang, J.W., Wu, M.S., et al. Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis. Nephrology (Carlton) 14 (2009), 59–64.
15. 15 Zhang, M., Wang, M., Li, H., et al. Association of Initial Twice-Weekly Hemodialysis Treatment with Preservation of Residual Kidney Function in ESRD Patients. Am J Nephrol 40 (2014), 140–150.
16. 16 Obi, Y., Streja, E., Rhee, C.M., et al. Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a cohort study. Am J Kidney Dis, 2016 Feb 9 [e-pub ahead of print] http://dx.doi.org/10.1053/j.ajkd.2016.01.008, accessed May 10, 2016.
17. 17 Bargman, J.M., Thorpe, K.E., Churchill, D.N., Group, C.P.D.S., Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 12 (2001), 2158–2162.
18. 18 Shemin, D., Bostom, A.G., Laliberty, P., Dworkin, L.D., Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 38 (2001), 85–90.
19. 19 Lin, X., Yan, Y., Ni, Z., et al. Clinical outcome of twice-weekly hemodialysis patients in shanghai. Blood Purif 33 (2012), 66–72.
20. 20 Hanson, J.A., Hulbert-Shearon, T.E., Ojo, A.O., et al. Prescription of twice-weekly hemodialysis in the USA. Am J Nephrol 19 (1999), 625–633.
21. 21 Obi Y, Rhee C, Mathew A, et al. Residual kidney function decline and mortality in incident hemodialysis patients. J Am Soc Nephrol, in press.
22. 22 O'Hare, A.M., Wong, S.P., Yu, M.K., et al. Trends in the timing and clinical context of maintenance dialysis initiation. J Am Soc Nephrol 26 (2015), 975–1981.
23. 23 Fernandez-Lucas, M., Teruel-Briones, J.L., Gomis-Couto, A., et al. Maintaining residual renal function in patients on haemodialysis: 5-year experience using a progressively increasing dialysis regimen. Nefrologia 32 (2012), 767–776.
24. 24 Shafi, T., Jaar, B.G., Plantinga, L.C., et al. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis 56 (2010), 348–358.
25. 25 Marquez, I.O., Tambra, S., Luo, F.Y., et al. Contribution of residual function to removal of protein-bound solutes in hemodialysis. Clin J Am Soc Nephrol 6 (2011), 290–296.
26. 26 Kabanda, A., Jadoul, M., Pochet, J.M., et al. Determinants of the serum concentrations of low molecular weight proteins in patients on maintenance hemodialysis. Kidney Int 45 (1994), 1689–1696.
27. 27 Penne, E.L., van der Weerd, N.C., Blankestijn, P.J., et al. Role of residual kidney function and convective volume on change in beta2-microglobulin levels in hemodiafiltration patients. Clin J Am Soc Nephrol 5 (2010), 80–86.
28. 28 Penne, E.L., van der Weerd, N.C., Grooteman, M.P., et al. Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients. Clin J Am Soc Nephrol 6 (2011), 281–289.
29. 29 Suri, R.S., Larive, B., Sherer, S., et al. Risk of vascular access complications with frequent hemodialysis. J Am Soc Nephrol 24 (2013), 498–505.
30. 30 Kalantar-Zadeh, K., Unruh, M., Zager, P.G., et al. Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy. Am J Kidney Dis 64 (2014), 181–186.
31. 31 Obi, Y., Eriguchi, R., Ou, S., Rhee, C., Kalantar-Zadeh, K., What is known and unknown about twice-weekly hemodialysis. Blood Purif 40 (2015), 298–305.
32. 32 Kuttykrishnan, S., Kalantar-Zadeh, K., Arah, O.A., et al. Predictors of treatment with dialysis modalities in observational studies for comparative effectiveness research. Nephrol Dial Transplant 30 (2015), 1208–1217.
33. 33 Daugirdas, J., Blake, P., Ing, T., Handbook of Dialysis. 2014, Lippincott Williams & Wilkins, Baltimore, MD.
34. 34 Daugirdas, J.T., Leypoldt, J.K., Akonur, A., et al. Improved equation for estimating single-pool Kt/V at higher dialysis frequencies. Nephrol Dial Transplant 28 (2013), 2156–2160.
35. 35 National Kidney Foundation. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis 66 (2015), 884–930.
36. 36 Mosteller, R.D., Simplified calculation of body-surface area. N Engl J Med, 317, 1987, 1098.
37. 37 Austin, P.C., Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28 (2009), 3083–3107.
38. 38 Schacht, A., Bogaerts, K., Bluhmki, E., Lesaffre, E., A new nonparametric approach for baseline covariate adjustment for two-group comparative studies. Biometrics 64 (2008), 1110–1116.
39. 39 Quan, H., Sundararajan, V., Halfon, P., et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43 (2005), 1130–1139.
40. 40 Rattanasompattikul, M., Feroze, U., Molnar, M.Z., et al. Charlson comorbidity score is a strong predictor of mortality in hemodialysis patients. Int Urol Nephrol 44 (2012), 1813–1823.
41. 41 Blackwell, M., Iacus, S., King, G., et al. CEM: coarsened exact matching in Stata. Stata J 9 (2009), 524–546 Available at: http://www.stata-journal.com/article.html?article=st0176 accessed October 2, 2015.